Universal Beteiligungs und Servicegesellschaft mbH Boosts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Universal Beteiligungs und Servicegesellschaft mbH boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the 3rd quarter, Holdings Channel reports. The fund owned 360,960 shares of the medical equipment provider’s stock after acquiring an additional 5,522 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Intuitive Surgical were worth $161,432,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the business. Tobam raised its position in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new stake in Intuitive Surgical in the second quarter valued at $27,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical during the second quarter worth about $30,000. Riggs Asset Managment Co. Inc. increased its position in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares in the last quarter. Finally, First Command Advisory Services Inc. lifted its holdings in shares of Intuitive Surgical by 3,750.0% in the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 75 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In related news, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 28,800 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.56, for a total value of $15,769,728.00. Following the transaction, the insider directly owned 27,027 shares in the company, valued at approximately $14,798,904.12. This represents a 51.59% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 114,007 shares of company stock worth $63,533,844 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $527.44 on Wednesday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm’s fifty day moving average price is $564.60 and its 200 day moving average price is $511.68. The company has a market capitalization of $189.08 billion, a price-to-earnings ratio of 69.77, a price-to-earnings-growth ratio of 4.35 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Evercore ISI set a $580.00 price target on shares of Intuitive Surgical in a research report on Monday, January 5th. UBS Group reiterated a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Daiwa Capital Markets increased their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Finally, Barclays reissued an “overweight” rating and issued a $686.00 price target (up from $635.00) on shares of Intuitive Surgical in a report on Wednesday, January 7th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $622.17.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.